Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 2231-2240 of 9365

Page
per page
  1. XL228
    A3939 XL228
    Summary: IGF1R/AURORA /FGFR1-3/ABL/SRC family kinases inhibitor
      ≥21.9 mg/mL
  2. XL388
    A3940 XL388
    Summary: MTOR inhibitor,highly potent and selective
      insoluble in EtOH; insoluble in H2O; ≥6.87 mg/mL
  3. XMD17-109
    A3942 XMD17-109
    Target: ERK
    Summary: ERK-5 inhibitor
      ≥31.95 mg/mL
  4. XMD8-92
    A3943 XMD8-92
    Target: ERK
    Summary: BMK1/ERK5 inhibitor
      ≥23.75 mg/mL
  5. X-NeuNAc
    A3944 X-NeuNAc
    Target: Neuraminidases (NA)
    Summary: Subtrate for chromogeneic assay of neuraminidase activity
      ≥28 mg/mL
  6. YK-4-279
    A3946 YK-4-279
    Target: RHA
    Summary: RNA Helicase A (RHA) inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  7. YM-155 hydrochloride
    A3947 YM-155 hydrochloride
    Summary: Potent survivin inhibitor
      ≥19.45 mg/mL
  8. Zardaverine
    A3950 Zardaverine
    Summary: PDE III and IV inhibitor
      Soluble in DMSO
  9. Ziprasidone
    A3952 Ziprasidone
    Summary: 5-HT (serotonin)/dopamine receptor antagonist
      ≥20.65 mg/mL
  10. Ziprasidone hydrochloride monohydrate
    A3953 Ziprasidone hydrochloride monohydrate
    Summary: 5-HT (serotonin)/dopamine receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥11.69 mg/mL

Items 2231-2240 of 9365

Page
per page